Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Jun 23, 2023 5:20pm
270 Views
Post# 35512163

RE:RE:RE:Timeline

RE:RE:RE:TimelineMy hunch is that the last thing they want is to spend the AGM hearing that people are unhappy about no money or no plan for money.

As such, I predict
- sometime in the next week, an announcement re so cash arrangement. JV would be nice but I suspect they just did another PP but to a bigger pool of investors such as ones that the new board member out of Boston may know.

If they announce some money obtained, then the share price may drift up while wait on BTD.

I don't see how they can avoid the BTD question at the AGM so should know then whether BTD has been submitted, OR will be submitted along some timeline.

Given the low turnover of shares and the number of longholders, if they can solve the cash crunch and get BTD, that would put share price back up to something close to the highs of last  year.

IMO

<< Previous
Bullboard Posts
Next >>